What payment methods are accepted?

We accept LC, T/T, D/P, PayPal, and small-amount payments.

What after-sales services are provided?

We offer online support and provide free spare parts.

What are the typical applications for this compressor?

It is suitable for car use, oxygen concentrators, and medical nebulizers.

Portable DC12V Air Compressor Small and Light

Name: Portable DC12V Air Compressor Small and Light
Brand: Sinc Gleeman Medical Technology(Changzhou) Co.,Ltd.
SKU: 2078987575

Jiangsu, ChinaSinc Gleeman Medical Technology(Changzhou) Co.,Ltd.

US$80.00-100.00

100 Pieces

Sample price:US$120.00/piece.Request sample

Product profile

Customization

Available

After-sales Service

on Line Support and Free Spare Parts

Voltage

DC 12V

Model NO.

SMK90D

Weight

0.8kg

Air Flow Rate

17L/Min@20 Psi

Speed

2100rpm

Temperature

32° to 104°f(0° to 60°c)

Power

85W

Noise

≤52dB(a)

Work Pressure

20psi(1.4bar)

Certificate

ETL

Packaging

Honeycomb Packaging + Wooden Pallet

Dimension

111X69X93.7 mm

Origin

China

HS Code

8414804990

Production Capacity

200000pieces/Year

Key features

Compact and Lightweight: Weighs only 0.8kg with dimensions of 111x69x93.7mm for easy portability.

High Efficiency Performance: Delivers 17L/min flow rate at 20 PSI with 2100 rpm variable speed.

Low Noise Operation: Operates quietly with noise levels of 52dB(a) or less.

Safety Certified: Meets ETL safety certification standards for reliable performance.

Versatile Applications: Ideal for car use, oxygen concentrators, and medical nebulizers.

Comprehensive After-Sales Support: Includes online support and free spare parts for long-term reliability.

Fast Lead Time: Average production lead time is within 15 working days year-round.

Company profile

Sinc Gleeman Medical Technology(Changzhou) Co.,Ltd.

Jiangsu, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2020-06-11Nearest Port: ShanghaiAverage Response Time: ≤2.85hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, EXW, CIF, DDP

AI-Powered supplier vetting

SummarySinc Gleeman Medical Technology (Changzhou) Co., Ltd. is identified as both a trading company and manufacturer/factory in China. The supplier reports substantial manufacturing infrastructure, including over 600 employees, a 61,000-square-meter facility, more than 10 production lines, vertical integration, and stated annual capacity of 4,000,000 oil-free air pumps. It exports to multiple regions and holds ISO 9001 and ISO 14001 certifications. The supplier also states that it supports OEM/ODM partnerships. However, many operational, R&D, service, traceability, and contract-related fields remain unknown. An SGS audit is documented with a validity period from June 18, 2024 to June 17, 2025, but the provided audit result code is not interpretable as a substantive performance conclusion.

Supplier typeThe supplier is explicitly classified as both a Trading Company and Manufacturer/Factory. Its stated die-casting, motor production, CNC finishing, automatic assembly, and vertically integrated supply-chain operations support the presence of manufacturing capability rather than trading-only activity.

CertificationsThe supplier reports ISO 14001 and ISO 9001 certification. An SGS audit is also documented, with a stated validity period from 2024-06-18 to 2025-06-17; however, the supplied audit result value is not sufficiently explained to assess the audit outcome.

Production capacityProduction capability is supported by more than 10 production lines, over 600 employees, a 61,000-square-meter factory, full production facilities and testing instruments, vertical integration, and stated annual capacity of 4,000,000 oil-free air pumps. The supplier also reports 3,000,000 oxygen concentrator compressor pieces in annual output information.

Customization capabilityThe supplier explicitly states that it works with global intelligent product brand owners, retailers, and distributors to establish OEM/ODM partnerships. However, the dedicated OEM capability, ODM service availability, and related R&D service fields are otherwise marked unknown, so the evidence confirms stated partnership intent but not the full scope of customization execution.